Exact Mass: 618.358824
Exact Mass Matches: 618.358824
Found 222 metabolites which its exact mass value is equals to given mass value 618.358824,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Minosaminomycin
3-O-cis-Coumaroylmaslinic acid
3-O-cis-Coumaroylmaslinic acid is found in fruits. 3-O-cis-Coumaroylmaslinic acid is isolated from Zizyphus jujuba (Chinese date Isolated from Zizyphus jujuba (Chinese date). 3-O-trans-Coumaroylmaslinic acid is found in fruits.
3-O-p-trans-Coumaroylalphitolic acid
3-O-p-cis-Coumaroylalphitolic acid is found in fruits. 3-O-p-cis-Coumaroylalphitolic acid is a constituent of the fruit of Ziziphus jujuba (Chinese date)
cis-p-Coumaroylcorosolic acid
cis-p-Coumaroylcorosolic acid is found in tea. cis-p-Coumaroylcorosolic acid is a constituent of Leptospermum scoparium (red tea). Constituent of Leptospermum scoparium (red tea). cis-p-Coumaroylcorosolic acid is found in tea.
Z-Ile-Glu(O-t-butyl)-Ala-Leucinal
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015853 - Cysteine Proteinase Inhibitors
Volasertib
PA(8:0/20:3(8Z,11Z,14Z)-2OH(5,6))
PA(8:0/20:3(8Z,11Z,14Z)-2OH(5,6)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/20:3(8Z,11Z,14Z)-2OH(5,6)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of 5,6-dihydroxyeicosatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(20:3(8Z,11Z,14Z)-2OH(5,6)/8:0)
PA(20:3(8Z,11Z,14Z)-2OH(5,6)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(20:3(8Z,11Z,14Z)-2OH(5,6)/8:0), in particular, consists of one chain of one 5,6-dihydroxyeicosatrienoyl at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
Colossolactone V
A tricyclic triterpenoid that is 3,4-secolanosta-8,24-diene-3,26-dioic acid 3-methylester substituted by acetoxy groups at positions 19 and 22 and a hydroxy group at position 4. It is isolated from the fruiting bodies of the Vietnamese mushroom Ganoderma colossum and displays inhibitory activity towards the enzyme HIV protease.
3-O-cis-Coumaroylmaslinic acid
3-O-p-trans-Coumaroylalphitolic acid
(2S,3R,4S,5R)-2-{[2-hydroxy-22-(2-hydroxypropan-2-yl)-3,8,8,17,19-pentamethyl-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracos-4-en-9-yl]oxy}oxane-3,4,5-triol
3beta,(24R),(28R)-trihydroxystigmasta-7,9(11)-dien-21,24-lactone-3-O-beta-D-glucopyranoside|vernocuminoside H
12-deacetyloxy-15alpha-hydroxy-23-epi-26-deoxyactein
3-O-(E)-Caffeoylursonic|3-O-(E)-caffeoylursonic acid
(3-O-trans-caffeoyl)morolic acid|3beta-trans-(3,4-dihydroxycinnamoyloxy)olean-18-en-28-oic acid
3beta-O-cis-caffeoyl betulinic acid|betulinic acid 3beta-cis-caffeate
3alpha-(3,4-dihydroxy-trans-cinnamoyloxy)-D-friedoolean-14-en-28-oic acid|3alpha-(3-,4-dihydroxy-trans-cinnamoyloxy)-D-friedoolean-14-en-28-oic acid|3alpha-[3,4-dihydroxy-trans-cinnamoyl]oxy-D-friedoolean-14-en-28-oic acid|3??-(3,4-Dihydroxy-trans-cinnamoyloxy)-D-friedo-olean-14-en-28-oic acid|myricarin A
(4aS,6aR,6bS,8aS,9R,12aS,12bS,14aR,14bS)-14a-({[(2E)-3-(4-Hydroxyphenyl)prop-2-enoyl]oxy}methyl)-2,2,6a,8a,9,12b-hexamethyl-10-oxoicosahydropicene-4a(2H)-carboxylic acid|27-[ (E)-coumaroyloxy]friedelin-28-carboxylic acid
6-Ketone, tetra-Ac-(3beta, 5alpha, 6beta, 15alpha, 16beta, 25S)-Cholestane-3, 6, 16, 23, 24-pentol
Petuniasterone B 22-O-<(methylthio)-carbonyl>acetate < (22R,24S)-1alpha-acetoxy-24,25-epoxy-7alpha-hydroxy-22-(methylthiocarbonyl)acetoxyoergost-4-en-3-one >|Petuniasterone B 22-O-[(methylthio)-carbonyl]acetate [ (22R,24S)-1alpha-acetoxy-24,25-epoxy-7alpha-hydroxy-22-(methylthiocarbonyl)acetoxyoergost-4-en-3-one ]
(23R,24S)-16beta,23;16alpha,24-diepoxy-cycloart-7-en-3beta,11beta,25-triol 3-O-beta-D-xylopyranose
(1S,5S,7R)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-5-[(E)-4-hydroxy-3,7-dimethylocta-2,6-dienyl]-8,8-dimethyl-1,7-bis(3-methylbut-2-enyl)bicyclo[3.3.1]non-3-ene-2,9-dione|32-hydroxy-ent-guttiferone M
3-(5,18-seco-ibogamin-13-yl)-vobasan-17-oic acid methyl ester|Deshydroxycapuvosine
C40H50N4O2 (618.3933559999999)
4alpha-methyl-5alpha-stigmast-7,24(28)-diene-21-carbothioic acid 3beta-O-alpha-L-quinovopyranoside|fruticoside G
3beta-O-beta-D-glucopyranosyloxy-16beta,29-dihydroxy-5alpha-stigmasta-7,9(11),24(28)Z-trien-6-one
3beta-hydroxy-27-p-Z-coumaroyloxyurs-12-en-28-oic acid
11alpha,12alpha:13beta,28-diepoxyoleanane-3beta-yl trans-caffeate
24,25-epoxy-3beta-O-beta-D-glucopyranosyloxy-5alpha-stigmasta-7,9(11),28-triene-6beta,16beta-diol
cholest-5-ene-2alpha,3alpha,7beta,15beta,18-pentol 2,7,15,18-tetraacetate
(21alpha)-21-hydroxythyrsiferol|(alpha(2)S,2R,4S,5R)-;alpha;(2)-{(3S)-3-{(2R,4aR,6R,8aS)-6-[(2S,5R)-5-bromotetrahydro-2,6,6-trimethyl-2H-pyran-2-yl]octahydro-8a-methylpyrano[3,2-b]pyran-2-yl}-3-hydroxybutyl}tetrahydro-4-hydroxy-alpha(5),alpha(5),2-trimethylfuran-2,5-dimethanol
1alpha,3beta,25-trihydroxy-16,23-dioxo-9,10-seco-9,19-cyclolanosta-5(10),9(11)-diene 3-O-alpha-L-arabinopyranoside|podocarpaside A
1beta,7beta,12beta,18-Tetraacetoxycholest-5-en-3beta-ol
methyl 3-beta,11alpha-diacetoxy-1alpha,2alpha,28-trihydroxyurs-12-en-24-oate
3beta-[(alpha-L-arabinopyranosyl)oxy]-16alpha,23-dihydroxyoleana-11,13(18)-dien-28-oic acid
11-benzoyl-14-([E]-3,7-dimethyl-2,6-octadienyl)-3-(1-hydroxy-1-methylethyl)-6,6,10,10-tetramethyl-4,5-dioxatetracyclo[7,3,3,1(11,14)0(1,7)]hexadecane-12,13,16-trione|otogirinin B
3beta-[(alpha-L-arabinopyranosyl)oxy]-16alpha-hydroxy-23-oxoolean-12-en-28-oic acid
3beta-O-cis-p-coumaroyl-20beta-hydroxy-12-ursen-28-oic acid
2, 7, 15, 18-Tetra-Ac-(2alpha, 3alpha, 7beta, 15beta)-Cholest-5-ene-2, 3, 7, 15, 18-pentol
C35H54O9_beta-D-Xylopyranoside, 1,3,4,6,7,7a,7b,8,9,10,11,13,13a,15,15a-pentadecahydro-13-hydroxy-11-(1-hydroxy-1-methylethyl)-1,1,7a,8,13a-pentamethyl-10,12a-epoxy-2H,5H-cyclopropa[1,8a]naphth[2,1:4,5]indeno[2,1-b]oxepin-2-yl
(2S,3R,4S,5R)-2-{[2-hydroxy-22-(2-hydroxypropan-2-yl)-3,8,8,17,19-pentamethyl-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracos-4-en-9-yl]oxy}oxane-3,4,5-triol_major
(2S,3R,4S,5R)-2-{[2-hydroxy-22-(2-hydroxypropan-2-yl)-3,8,8,17,19-pentamethyl-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracos-4-en-9-yl]oxy}oxane-3,4,5-triol_25.8\\%
(2S,3R,4S,5R)-2-{[2-hydroxy-22-(2-hydroxypropan-2-yl)-3,8,8,17,19-pentamethyl-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracos-4-en-9-yl]oxy}oxane-3,4,5-triol_49.7\\%
cis-p-Coumaroylcorosolic acid
desferrioxamine G
2,2-DI(4-TERT-OCTYLPHENYL)-1-PICRYL-HYDRAZYL, FREE RADICAL
C34H44N5O6 (618.3291423999999)
tris(2,2,6,6-tetramethyl-3,5-heptanedionato)gallium(iii)
Volasertib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
Pyracrenic acid
(E)-(S)-4-[(S)-4-Methyl-2-((S)-3-methyl-2{(S)-2-[(5-methyl-isoxazole-3-carbonyl)-amino]-propionylamino}-butyrylamino)-pentanoylamino]-5-((S)-2-oxo-pyrrolidin-3-YL)-pent-2-enoic acid ethyl ester
2-[[(2R)-3-acetyloxy-2-[(5R,6Z,8E,10E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-2-acetyloxy-3-[(5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-3-acetyloxy-2-[(5S,6E,8Z,11Z,13E,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-2-acetyloxy-3-[(5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-3-acetyloxy-2-[(5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-2-acetyloxy-3-[(5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-O-E-p-coumaroyl alphitolic acid
A pentacyclic triterpenoid that is lup-20(29)-en-28-oic acid substituted by a hydroxy group at position 3 and a [(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy group at position 2 (the 2alpha,3beta-stereoisomer ). It has been isolated from the root bark of Zizyphus jujuba and Ziziphus cambodianus.
Fruticoside G
A steroid saponin that is 4-methylstigmasta-7,24(28)-diene-21-thioic S-acid attached to an alpha-L-quinovopyranosyloxy group at position 3 (the 3beta,4alpha,5alpha,24Z stereoisomer). It has been isolated from the roots of Breynia fruticosa.
3beta-O-cis-caffeoylbetulinic acid
A natural product found in Durio carinatus.
32-Hydroxy-ent-guttiferone M
A natural product found in Rheedia edulis.
S-[2-[3-[[(2R)-2-hydroxy-3,3-dimethyl-4-phosphonooxybutanoyl]amino]propanoylamino]ethyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienethioate
[1-decoxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propan-2-yl] decanoate
2-(3-((Z)-3-Tributylstannyl-1-propenoxy)-(2R,3S,5AR,6AS,10AR,12AS)-tetrahydropyrano(3,2-B)oxepano(2,3:6,7)oxepan-2-YL)ethanal
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate
[1-[(2-heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-nonanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate
[1-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxy-3-phosphonooxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate
(2S)-2-[[(2S)-3-[(4R)-2-amino-4,5-dihydro-1H-imidazol-4-yl]-1-[[(2S,3S,5R,6S)-4-[(2R,3S,5S,6R)-3,5-diamino-6-methyloxan-2-yl]oxy-2,3,5,6-tetrahydroxycyclohexyl]amino]-1-oxopropan-2-yl]carbamoylamino]-4-methylpentanoic acid
3beta-O-trans-caffeoylbetulinic acid
A natural product found in Durio carinatus.
2alpha,7beta,15beta,18-tetraacetoxy-cholest-5-en-3alpha-ol
PAR-4 (1-6) amide (human)
PAR-4 (1-6) amide human is an N-terminal fragment of protease-activated receptor 4 (PAR4). PAR-4 (1-6) amide human induce platelet aggregation[1].